A family-, women- and minority-owned firm, Bluegrass secured a gathering with the entertainer, entrepreneur and philanthropist in 2019 and pitched him its line of CBD-infused merchandise and its know-how. Nelly agreed, changing into not solely a model ambassador, but additionally securing an possession stake, based on Jonathan Tumey, the corporate’s chief know-how officer.
“His goals were aligned with our business and our mission,” Tumey informed the Dayton Every day Information. “He was interested and wanted to be part of this opportunity in our organization.”
CBD is a chemical present in marijuana that doesn’t include THC, the primary psychoactive compound in hashish.
Bluegrass Farmaceuticals’ massive portfolio contains hemp-derived drinks, edibles and merchandise with out THC. They embrace pharmaceutical-grade elements with no components, preservatives or harmful chemical compounds, based on the corporate.
Tumey mentioned that’s primarily what drew the curiosity of Nelly, whose actual title is Cornell Haynes Jr.
Bluegrass Farmaceuticals opened its Miamisburg facility at 965 Capstone Drive within the Mound Enterprise Park in 2019 with one 1,000-square toes room. It since has bought one other room that’s twice that measurement and is renovating the area..
The corporate, which is headquartered in Belton, Ky., expects to double or triple the dimensions of its Miamisburg location over the subsequent a number of years, he mentioned.
“The Mound … they’ve been excellent to us,” Tumey mentioned. “They’re an excellent spot for anybody who would be interested in laboratories.”
Merchandise are hand-crafted and formulated in Miamisburg, together with the KLOUD5 line of vaping merchandise the corporate launched in September 2020.
Nelly performed a big function in shaping the road, together with the iKON vaping machine used to eat Bluegrass’ CBD E-Liquids, telling the corporate what he preferred and didn’t like.
“He kind of steered the car, if you will, in terms of the product development,” Tumey mentioned.
The KLOUD5 product line is “on a solid trajectory,” he mentioned, including that the corporate is hitting its targets for the 12 months.
“Bluegrass Farmaceuticals’ consumer-centric approach and their refusal to compromise on quality and purity excites me,” Nelly mentioned in an announcement. “Our products take cannabis-infused vaping to the next level, which means responsible adults can enjoy these products in a superior way. I’m proud to be the company’s partner in this.”
Bluegrass Farmaceuticals has 13 patents pending for its applied sciences. The corporate mentioned it’s growing and commercializing superior therapeutic units for in-home extraction and consumption of hashish therapeutics, making hashish consumption extra handy for customers.
“We kind of hang our hat on being not just a CBD compliant, but a high-tech, biotech kind of company,” Tumey mentioned. “We’re heavily involved in intellectual property (and) we’re experts at formulating.”
A lot of Bluegrass Farmaceuticals’ income is pushed from direct-to-consumer strains and far of the expansion it’s seeing is contract manufacturing for present Ohio hemp cultivators, together with Energy of the Flower and Ohio State Hemp.
“They grow, we process,” Tumey mentioned. “We’re basically a full-service laboratory turnkey, and that’s what they like. We hand you, at the end of the day, a sellable product and we do it in a reasonable amount of time.”